Fresenius Medical Care introduces 2008K@home™ hemodialysis delivery system in North America
November 10 2011 - 8:00AM
Business Wire
Fresenius Medical Care AG & Co. KGaA (“the company” or
“Fresenius Medical Care”; Frankfurt Stock Exchange: FME / New York
Stock Exchange: FMS), the world’s largest provider of dialysis
products and services, today introduced the 2008K@home, a
hemodialysis system for use at the patient’s home, at the American
Society of Nephrology’s Kidney Week 2011 meeting in Philadelphia,
USA. The 2008K@home machine is built on the 2008® series
hemodialysis machine platform that has delivered superior
hemodialysis therapy for over 30 years. This machine combines
safety, efficacy and reliability with a simple user-interface that
incorporates an on-screen tutorial to walk the user through set-up,
treatment, and disconnection from therapy. Earlier this year, the
U.S. Food and Drug Administration (FDA) cleared the 2008K@home
machine for use.
“With the growing interest in home therapies in the U.S., the
2008K@home machine provides another option for delivering
hemodialysis to patients who want the freedom associated with being
at home,” said Maureen Lyden-Green, Vice President for Home
Therapies at Fresenius Medical Care North America. “The 2008K@home
provides patients with a smaller version of the in-center machine
and allows flexibility to deliver a customized physician’s dialysis
prescription for each patient, meeting the patient’s medical needs
and suiting their lifestyle,” continued Chief Medical and
Regulatory Affairs Officer Dr. Jose Diaz-Buxo.
Fresenius Medical Care is the world's largest integrated
provider of products and services for individuals undergoing
dialysis because of chronic kidney failure, a condition that
affects more than 2 million individuals worldwide. Through its
network of 2,874 dialysis clinics in North America, Europe, Latin
America, Asia-Pacific and Africa, Fresenius Medical Care provides
dialysis treatment to 228,239 patients around the globe. Fresenius
Medical Care is also the world's leading provider of dialysis
products such as hemodialysis machines, dialyzers and related
disposable products.
For more information about Fresenius Medical Care, visit the
Company’s website at www.fmc-ag.com.
Disclaimer
This release contains forward-looking statements that are
subject to various risks and uncertainties. Actual results could
differ materially from those described in these forward-looking
statements due to certain factors, including changes in business,
economic and competitive conditions, regulatory reforms, foreign
exchange rate fluctuations, uncertainties in litigation or
investigative proceedings, and the availability of financing. These
and other risks and uncertainties are detailed in Fresenius Medical
Care AG & Co. KGaA's reports filed with the U.S. Securities and
Exchange Commission. Fresenius Medical Care AG & Co. KGaA does
not undertake any responsibility to update the forward-looking
statements in this release.
Fresenius Medical Care (TG:FME)
Historical Stock Chart
From Jun 2024 to Jul 2024
Fresenius Medical Care (TG:FME)
Historical Stock Chart
From Jul 2023 to Jul 2024